Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients

CompletedOBSERVATIONAL
Enrollment

233

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

June 22, 2017

Conditions
Cancer
Trial Locations (16)

Unknown

"IRCCS Istituto OncologicoGiovanni Paolo II", Bari

"Ospedale A.Perrino", Brindisi

Istituti Ospitalieri, Cremona

IRCCS AOU San Martino -IST, Genova

AOU Policlinico G.Martino, Messina

Istituto Nazionale Tumori, Milan

Istituto Nazionale Tumori - Fondazione Pascale, Napoli

Istituto Oncologico Veneto, Padua

IRCCS Policlinico S.Matteo, Pavia

A.O. Sant'Andrea, Roma

Ospedale San Camillo Forlanini, Roma

Policlinico Umberto I, Roma

Ospedale Civile SS.Annunziata, Sassari

Ospedale Valdelsa di Poggibonsi, Siena

AOU San Luigi Orbassano, Torino

Policlinico Universitario G.B.Rossi, Verona

All Listed Sponsors
collaborator

National Cancer Institute, Naples

OTHER

collaborator

F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations

UNKNOWN

collaborator

SmithKline Foundation

UNKNOWN

collaborator

Parma University Hospital

OTHER

collaborator

IRCCS AOU San Martino -IST Genoa

UNKNOWN

collaborator

Istituti Ospitalieri di Cremona

OTHER

collaborator

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

lead

Italian PRO-CTCAE Study Group

OTHER

NCT02381054 - Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients | Biotech Hunter | Biotech Hunter